Add Company
Join Now

Orflo Technologies Revenue and Competitors

License our Company Data API

Ketchum, ID

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Orflo Technologies's estimated annual revenue is currently $1.7M per year.(i)
  • Orflo Technologies's estimated revenue per employee is $155,000

Employee Data

  • Orflo Technologies has 11 Employees.(i)
  • Orflo Technologies grew their employee count by 10% last year.

Orflo Technologies's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
CEOReveal Email/Phone
3
Chief Technology OfficerReveal Email/Phone
4
Senior Director Hardware and Software EngineeringReveal Email/Phone
5
Operations ManagerReveal Email/Phone
6
Manufacturer Engineer at Orflo TechnologiesReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$2.3M1515%N/AN/A
#2
$3.3M21-28%N/AN/A
#3
$3.3M21-5%N/AN/A
#4
$1.7M1110%N/AN/A
#5
$0.9M6-40%N/AN/A
#6
$2.5M16-11%N/AN/A
#7
$9.5M619%N/AN/A
#8
$1.6M100%N/AN/A
#9
$2.6M1713%N/AN/A
#10
$0.3M2-50%N/AN/A
Add Company

What Is Orflo Technologies?

Orflo Technologies is a life sciences company developing and marketing powerful yet simple instrumentation to the cell and protein analysis industries. At the core of Orflo’s instrumentation is a patent protected µFlow Cell Cassette. Through the unique combination of impedance (Coulter Principle) and fluorescence based flow Cytometry Orflo’s instruments provide an informative and intuitive window into cell analysis by directly measuring fluorescence and cell volume simultaneously. This coupled with the industry leading ease of use, affordability, elimination of all fluidics and maintenance will enable a significant increase in the pace of experimentation, testing and ultimately discovery.

keywords:N/A

N/A

Total Funding

11

Number of Employees

$1.7M

Revenue (est)

10%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.6M15-48%N/A
#2
$2.4M150%N/A
#3
$3.2M2011%N/A
#4
N/A2124%N/A
#5
$3.5M30-6%N/A